04:15 PM EDT, 03/12/2024 (MT Newswires) -- Outlook Therapeutics ( OTLK ) said Tuesday that the planned 1-for-20 reverse stock split will be effective from Thursday's regular trading session.

The reverse stock split is part of ophthalmic medication company's plan to regain compliance with Nasdaq's minimum bid price rules.

Outlook shares closed nearly 11% lower in regular session.